Resultados de la búsqueda 211-220 of 10043 for Cycle

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  2. Ensayos clínicos - Neurocirugía

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  4. Oncología (médica) - Ensayos clínicos

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  5. Oncología (médica) - Ensayos clínicos

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  6. Neurología - Ensayos clínicos

    The purpose of this study is to assess the safety, tolerability, and effectiveness of additional 6-week treatment cycles with Rozanolixizumab in study ...

  7. Mayo Clinic Physician Update - July 2024

    Page 1.

  8. Oncología (médica) - Ensayos clínicos

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  9. Oncología (médica) - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  10. Ensayos clínicos - Neurocirugía

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...